Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (

TheStreet

) -- Most government statistics don't mean a thing to the stock market, Jim Cramer told his

Mad Money

 viewers Tuesday. But when you get a

gross domestic product number

 as robust as we received today, well, that's hard to ignore.

Cramer said money managers will see today's GDP number as a sign to buy, buy, buy, which makes the perfect stock for this moment Kimberly-Clark (KMB) - Get Kimberly-Clark Corporation (KMB) Report . Why Kimberly? Because when you buy diapers, you're buying an oil-based product that just got a lot cheaper to source, make and ship to consumers. You also get a company with big profits and dividend protection.

A robust economy is also a big win for retailers like Costco (COST) - Get Costco Wholesale Corporation Report , Cramer noted, along with winners like Restoration Hardware (RH) - Get RH (Restoration Hardware) Report and Walgreens (WAG) , a stock Cramer owns for his charitable trust, Action Alerts PLUS and which just reported its first good quarter in ages.

Cramer was also bullish on restaurants such as AAP holding Starbucks (SBUX) - Get Starbucks Corporation Report and Popeyes Louisiana Kitchen (PLKI) , along with non-residential construction plays such as Honeywell (HON) - Get Honeywell International Inc. (HON) Report and Eaton (ETN) - Get Eaton Corp. Plc Report , another AAP stock.

With a strong GDP, Cramer is also bullish on Marriott International (MAR) - Get Marriott International, Inc. (MAR) Report and Boeing (BA) - Get Boeing Company Report .

Cramer's only words of caution were for the energy sector, as oil continues to find a bottom, and biotechs, which are falling victim to increased price competition.

Off the Charts

In the "Off The Charts" segment, Cramer went head to head with colleague Dan Fitzpatrick to determine how much lower the biotech sector can fall on the heels of Gilead Sciences' (GILD) - Get Gilead Sciences, Inc. (GILD) Report near 11% decline in recent days due to increased price competition.

Using a daily chart of the iShares Nasdaq Biotech ETF (IBB) - Get iShares NASDAQ Biotechnology ETF Report , Fitzpatrick noted the group's astounding leadership so far this year, up 29% and a full 42% from its April lows.

But Fitzpatrick cautioned the biotech stocks are at a crucial level, having fallen back to their 50-day moving average. If this level fails to hold, then $294 will be the next key level to watch, with only $261, the exchange-traded fund's 200-day moving average offering any floor of support below that.

Looking at a weekly chart, Fitzpatrick noted just three pullbacks since 2012 that approached the 40-week, or 200-day, moving average. The 200-day has been a terrific buying opportunity; unfortunately, that level is still 11% lower from where we are today.

Cramer agreed with Fitzpatrick, saying that if the 50-day average holds then it would be time to buy back into this group. But if the 40-day average fails, there's a long, long way to go before the next level of support comes into play.

Navigating Through the Rubble

It's still too early to begin picking among the rubble in the energy sector, Cramer told viewers, but that doesn't mean there aren't bargains to be had in stocks that have been wrongfully accused of being energy stocks. That's certainly the case with Navigator Holdings (NVGS) - Get Navigator Holdings Ltd. Report , Cramer pointed out. This purveyor of liquified natural gas ships doesn't have anything to do with the price of oil or gas.

Shares of Navigator are down a stunning 40% from their highs, Cramer noted. Investors have mistakenly viewed the company as another casualty of falling energy prices. But what matters to Navigator is not the price of what it carries in its 26 vessels, but the imbalance of where gas is found versus where it needs to go.

TheStreet Recommends

Navigator benefits from classic supply and demand: surplus versus shortage. The U.S. currently has a ton of excess natural gas while the rest of the world is in dire need of more. The U.S. has no less than five export terminals currently under construction. Just one of those terminals, the one being developed by Enterprise Product Partners (EPD) - Get Enterprise Products Partners L.P. Report , is set to open in late 2015 and is already 85% subscribed. That terminal alone will need 25 new ships to transport its gas.

And what of famed investor Wilbur Ross selling his stake in the company? Cramer said Ross' move was likely just profit taking after a near 300% gain.

Cramer said Navigator is a terrific bargain, even after its shares shot up 2.5% in today's session.

Executive Decision: Mark Dankberg

For his "Executive Decision" segment, Cramer checked in with Mark Dankberg, chairman and CEO of ViaSat (VSAT) - Get ViaSat, Inc. Report , the satellite-based broadband provider for airlines and consumers.

Dankberg said ViaSat has been providing in-flight communication services for government and business aircraft for many years now, but thanks to its latest satellite offerings is now expanding into in-flight wifi for airlines and commercial flights. He said given the frustration travelers have with in-flight Wi-Fi, that service tends to get most of the attention.

But Dankberg also noted that with the compelling need for surveillance and intelligence worldwide, ViaSat's government offerings are still playing an important role. He also called out ViaSat's cyber security offerings, which will be rolling out to utility companies in 2015, as another exciting area for growth.

Cramer said that when you have the best technology in a given industry you have a compelling story. That's what ViaSat offers investors.

Lightning Round

In the Lightning Round, Cramer was bullish on GW Pharmaceuticals (GWPH) - Get GW Pharmaceuticals PLC Sponsored ADR Report , SunTrust Banks (STI) - Get SunTrust Banks, Inc. Report , Cabot Oil & Gas (COG) - Get Cabot Oil & Gas Corporation Report and Bristol-Myers Squibb (BMY) - Get Bristol-Myers Squibb Company Report .

Cramer was bearish on Arlington Asset Investment (AI) - Get Arlington Asset Investment Corp. Class A Report , Prospect Capital (PSEC) - Get Prospect Capital Corporation Report , Range Resources (RRC) - Get Range Resources Corporation Report and Second Sight Medical Products (EYES) - Get Second Sight Medical Products, Inc. Report .

No Huddle Offense

In his "No Huddle Offense" segment, Cramer pondered how the defense stocks can be doing so well given all the downsizing and sequestration of recent years. The reason? The world is re-arming, he said, and the U.S. is the only arsenal large enough to meet the demand.

Cramer said the world is slowly coming to terms with the notion that the U.S. may no longer be the world's policeman, leaving the conflicts of Ukraine and the Middle East, among others, in the hands of those countries.

That means the world needs multi-billions of dollars of equipment from the likes of Raytheon (RTN) - Get Raytheon Company Report , Northrop Grumman (NOC) - Get Northrop Grumman Corporation Report and Lockheed Martin (LMT) - Get Lockheed Martin Corporation (LMT) Report . That's also why these companies have been reporting multi-billion-dollar deals with countries around the globe.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter

@ScottRutt

or get updates on Facebook,

ScottRuttDC

At the time of publication, Cramer's Action Alerts PLUS had a position in ETN, SBUX, STI and WAG.